Virginie Perrin

1.2k total citations
9 papers, 779 citations indexed

About

Virginie Perrin is a scholar working on Virology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Virginie Perrin has authored 9 papers receiving a total of 779 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Virology, 3 papers in Infectious Diseases and 3 papers in Molecular Biology. Recurrent topics in Virginie Perrin's work include HIV Research and Treatment (6 papers), Sarcoma Diagnosis and Treatment (2 papers) and HIV/AIDS drug development and treatment (2 papers). Virginie Perrin is often cited by papers focused on HIV Research and Treatment (6 papers), Sarcoma Diagnosis and Treatment (2 papers) and HIV/AIDS drug development and treatment (2 papers). Virginie Perrin collaborates with scholars based in France, South Korea and Morocco. Virginie Perrin's co-authors include Gaëlle Pierron, Franck Tirode, Olivier Delattre, Stéphanie Reynaud, Jean‐Michel Coindre, Stelly Ballet, Carlo Lucchesi, Sarah Cohen‐Gogo, Fabrizio Mammano and Olivier Schwartz and has published in prestigious journals such as Nature Genetics, Cancer Research and Journal of Virology.

In The Last Decade

Virginie Perrin

9 papers receiving 773 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Virginie Perrin France 8 486 218 178 173 166 9 779
Dawn Bockus United States 15 262 0.5× 68 0.3× 163 0.9× 87 0.5× 78 0.5× 24 587
James Fetten United States 14 214 0.4× 75 0.3× 267 1.5× 20 0.1× 74 0.4× 29 680
S Falk Germany 11 148 0.3× 52 0.2× 336 1.9× 30 0.2× 49 0.3× 33 739
Paul L. Klarenbeek Netherlands 19 57 0.1× 152 0.7× 185 1.0× 269 1.6× 35 0.2× 35 1.0k
Franque Remington United States 13 206 0.4× 57 0.3× 124 0.7× 72 0.4× 59 0.4× 20 448
Aydanur Kargı Türkiye 14 211 0.4× 131 0.6× 208 1.2× 52 0.3× 119 0.7× 60 649
RK Brynes United States 19 66 0.1× 119 0.5× 451 2.5× 52 0.3× 555 3.3× 37 1.2k
John A. Doyle United States 16 213 0.4× 108 0.5× 106 0.6× 403 2.3× 193 1.2× 30 932
Torsten Witte Germany 19 66 0.1× 127 0.6× 161 0.9× 207 1.2× 87 0.5× 50 965
J.-F. Michiels France 12 94 0.2× 54 0.2× 300 1.7× 26 0.2× 220 1.3× 32 638

Countries citing papers authored by Virginie Perrin

Since Specialization
Citations

This map shows the geographic impact of Virginie Perrin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Virginie Perrin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Virginie Perrin more than expected).

Fields of papers citing papers by Virginie Perrin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Virginie Perrin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Virginie Perrin. The network helps show where Virginie Perrin may publish in the future.

Co-authorship network of co-authors of Virginie Perrin

This figure shows the co-authorship network connecting the top 25 collaborators of Virginie Perrin. A scholar is included among the top collaborators of Virginie Perrin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Virginie Perrin. Virginie Perrin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Watson, Sarah, Virginie Perrin, Delphine Guillemot, et al.. (2018). Transcriptomic definition of molecular subgroups of small round cell sarcomas. The Journal of Pathology. 245(1). 29–40. 209 indexed citations
2.
Surdez, Didier, Magdalena Benetkiewicz, Virginie Perrin, et al.. (2012). Targeting the EWSR1-FLI1 Oncogene-Induced Protein Kinase PKC-β Abolishes Ewing Sarcoma Growth. Cancer Research. 72(17). 4494–4503. 44 indexed citations
3.
Pierron, Gaëlle, Franck Tirode, Carlo Lucchesi, et al.. (2012). A new subtype of bone sarcoma defined by BCOR-CCNB3 gene fusion. Nature Genetics. 44(4). 461–466. 328 indexed citations
4.
Genovesio, Auguste, Yong‐Jun Kwon, Marc P. Windisch, et al.. (2011). Automated Genome-Wide Visual Profiling of Cellular Proteins Involved in HIV Infection. SLAS DISCOVERY. 16(9). 945–958. 42 indexed citations
5.
Sourisseau, Marion, et al.. (2009). Partial Inhibition of Human Immunodeficiency Virus Replication by Type I Interferons: Impact of Cell-to-Cell Viral Transfer. Journal of Virology. 83(20). 10527–10537. 48 indexed citations
6.
Sourisseau, Marion, et al.. (2009). Partial inhibition of HIV replication by type-I interferons: impact of cell-to-cell viral transfer. Retrovirology. 6(S2). 6 indexed citations
7.
Andréoletti, Laurent, Katharina Skrabal, Virginie Perrin, et al.. (2007). Genetic and Phenotypic Features of Blood and Genital Viral Populations of Clinically Asymptomatic and Antiretroviral-Treatment-Naive Clade A Human Immunodeficiency Virus Type 1-Infected Women. Journal of Clinical Microbiology. 45(6). 1838–1842. 19 indexed citations
8.
Perrin, Virginie & Fabrizio Mammano. (2003). Parameters Driving the Selection of Nelfinavir-Resistant Human Immunodeficiency Virus Type 1 Variants. Journal of Virology. 77(18). 10172–10175. 27 indexed citations
9.
Hazan, Uriel, Ignacio A. Romero, Raffaella Cancello, et al.. (2002). Human adipose cells express CD4, CXCR4, and CCR5 receptors: a new target cell type for the immunodeficiency virus‐1?. The FASEB Journal. 16(10). 1254–1256. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026